Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

8E5A

Human L-type voltage-gated calcium channel Cav1.3 treated with 1.4 mM Sofosbuvir at 3.3 Angstrom resolution

Summary for 8E5A
Entry DOI10.2210/pdb8e5a/pdb
EMDB information27908
DescriptorVoltage-dependent L-type calcium channel subunit alpha-1D, Voltage-dependent calcium channel subunit alpha-2/delta-1, Voltage-dependent L-type calcium channel subunit beta-3, ... (8 entities in total)
Functional Keywordscav1.3, channels, calcium ion-selective, transport protein
Biological sourceHomo sapiens (human)
More
Total number of polymer chains3
Total formula weight427972.21
Authors
Gao, S.,Yao, X.,Yan, N. (deposition date: 2022-08-20, release date: 2022-12-07, Last modification date: 2025-05-28)
Primary citationYao, X.,Gao, S.,Wang, J.,Li, Z.,Huang, J.,Wang, Y.,Wang, Z.,Chen, J.,Fan, X.,Wang, W.,Jin, X.,Pan, X.,Yu, Y.,Lagrutta, A.,Yan, N.
Structural basis for the severe adverse interaction of sofosbuvir and amiodarone on L-type Ca v channels.
Cell, 185:4801-4810.e13, 2022
Cited by
PubMed Abstract: Drug-drug interaction of the antiviral sofosbuvir and the antiarrhythmics amiodarone has been reported to cause fatal heartbeat slowing. Sofosbuvir and its analog, MNI-1, were reported to potentiate the inhibition of cardiomyocyte calcium handling by amiodarone, which functions as a multi-channel antagonist, and implicate its inhibitory effect on L-type Ca channels, but the molecular mechanism has remained unclear. Here we present systematic cryo-EM structural analysis of Ca1.1 and Ca1.3 treated with amiodarone or sofosbuvir alone, or sofosbuvir/MNI-1 combined with amiodarone. Whereas amiodarone alone occupies the dihydropyridine binding site, sofosbuvir is not found in the channel when applied on its own. In the presence of amiodarone, sofosbuvir/MNI-1 is anchored in the central cavity of the pore domain through specific interaction with amiodarone and directly obstructs the ion permeation path. Our study reveals the molecular basis for the physical, pharmacodynamic interaction of two drugs on the scaffold of Ca channels.
PubMed: 36417914
DOI: 10.1016/j.cell.2022.10.024
PDB entries with the same primary citation
Experimental method
ELECTRON MICROSCOPY (3.3 Å)
Structure validation

237735

数据于2025-06-18公开中

PDB statisticsPDBj update infoContact PDBjnumon